{"id":1642,"date":"2022-02-03T23:39:31","date_gmt":"2022-02-03T22:39:31","guid":{"rendered":"https:\/\/www.urolon.com\/over-urolon\/clinical-data\/"},"modified":"2026-06-10T21:48:37","modified_gmt":"2026-06-10T19:48:37","slug":"clinical-data","status":"publish","type":"page","link":"https:\/\/www.urolon.com\/nl\/about-urolon\/clinical-data\/","title":{"rendered":"Clinical Data"},"content":{"rendered":"\t<div id=\"gap-1655087911\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-1655087911 {\n  padding-top: 60px;\n}\n@media (min-width:550px) {\n  #gap-1655087911 {\n    padding-top: 30px;\n  }\n}\n<\/style>\n\t<\/div>\n\t\n\n\t<section class=\"section\" id=\"section_834003065\">\n\t\t<div class=\"section-bg fill\" >\n\t\t\t\t\t\t\t\t\t\n\t\t\t\n\n\t\t<\/div>\n\n\t\t\n\n\t\t<div class=\"section-content relative\">\n\t\t\t\n<div class=\"row\"  id=\"row-1855389487\">\n\n\t<div id=\"col-2013896906\" class=\"col medium-8 small-12 large-8\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n\t<div class=\"img has-hover x md-x lg-x y md-y lg-y\" id=\"image_1249954637\">\n\t\t\t\t\t\t<div data-animate=\"fadeInDown\">\t\t<div class=\"img-inner dark\" style=\"margin:0px -15px -100px 0px;\">\n\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"1020\" height=\"1020\" src=\"https:\/\/www.urolon.com\/wp-content\/uploads\/2022\/02\/data.svg\" class=\"attachment-large size-large\" alt=\"\" \/>\t\t\t\t\t\t\n\t\t\t\t\t<\/div>\n\t\t<\/div>\t\t\t\t\t\t\n<style>\n#image_1249954637 {\n  width: 60%;\n}\n<\/style>\n\t<\/div>\n\t\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-2013896906 > .col-inner {\n  margin: 0px 0px -369px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n<\/div>\n<div class=\"row align-middle align-center\"  id=\"row-430258888\">\n\n\t<div id=\"col-1946519446\" class=\"col medium-10 small-11 large-5\"  data-animate=\"bounceInLeft\">\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n\t<div id=\"text-1372581050\" class=\"text\">\n\t\t\n<h1 class=\"p1\">Clinical Data<\/h1>\n\t\t\n<style>\n#text-1372581050 {\n  font-size: 2rem;\n}\n<\/style>\n\t<\/div>\n\t\n<p class=\"p1\">The use of a polycaprolactone based biostimulatory urethral implant for the treatment of female stress urinary incontinence (SUI); a pivotal trial.<\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-1946519446 > .col-inner {\n  margin: 0px -97px 0px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-496449102\" class=\"col hide-for-medium medium-1 small-12 large-6\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\n\t\n<\/div>\n\t\t<\/div>\n\n\t\t\n<style>\n#section_834003065 {\n  padding-top: 34px;\n  padding-bottom: 34px;\n}\n@media (min-width:550px) {\n  #section_834003065 {\n    padding-top: 90px;\n    padding-bottom: 90px;\n  }\n}\n<\/style>\n\t<\/section>\n\t\n\n\t<section class=\"section\" id=\"section_1866695324\">\n\t\t<div class=\"section-bg fill\" >\n\t\t\t\t\t\t\t\t\t\n\t\t\t\n\n\t\t<\/div>\n\n\t\t\n\n\t\t<div class=\"section-content relative\">\n\t\t\t\n<div class=\"row align-middle align-center\"  id=\"row-823793209\">\n\n\t<div id=\"col-1516427352\" class=\"col medium-11 small-11 large-11\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<p class=\"p1\"><b>February 2022<\/b><\/p>\n<p class=\"p1\">The 2-year follow-up data further confirms the earlier findings of the Urolon clinical effectiveness. Urolon shows to be a safe and effective treatment option for females with mild to moderate SUI who have attempted or failed pelvic floor muscle training. Urolon treatment resulted in improvements in efficacy and patient\u2019s Quality of Life, while being well tolerated. The bioresorption profile of Urolon\u2122 remains a very attractive characteristic as this is a highly sought-after feature.<\/p>\n<div class=\"row\"  id=\"row-2026027340\">\n\n\t<div id=\"col-114419578\" class=\"col medium-4 small-12 large-4\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n\t<div class=\"img has-hover x md-x lg-x y md-y lg-y\" id=\"image_1630226728\">\n\t\t\t\t\t\t\t\t<div class=\"img-inner dark\" >\n\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"1020\" height=\"1020\" src=\"https:\/\/www.urolon.com\/wp-content\/uploads\/2022\/02\/Modellen-1024x1024.jpg\" class=\"attachment-large size-large\" alt=\"\" srcset=\"https:\/\/www.urolon.com\/wp-content\/uploads\/2022\/02\/Modellen-1024x1024.jpg 1024w, https:\/\/www.urolon.com\/wp-content\/uploads\/2022\/02\/Modellen-1000x1000.jpg 1000w, https:\/\/www.urolon.com\/wp-content\/uploads\/2022\/02\/Modellen-768x768.jpg 768w, https:\/\/www.urolon.com\/wp-content\/uploads\/2022\/02\/Modellen-1536x1536.jpg 1536w, https:\/\/www.urolon.com\/wp-content\/uploads\/2022\/02\/Modellen-2048x2048.jpg 2048w\" sizes=\"auto, (max-width: 1020px) 100vw, 1020px\" \/>\t\t\t\t\t\t\n\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\n<style>\n#image_1630226728 {\n  width: 100%;\n}\n<\/style>\n\t<\/div>\n\t\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\n\t\n\n\t<div id=\"col-1477818874\" class=\"col medium-4 small-12 large-4\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n\t<div class=\"img has-hover x md-x lg-x y md-y lg-y\" id=\"image_1242097839\">\n\t\t\t\t\t\t\t\t<div class=\"img-inner dark\" >\n\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"1020\" height=\"1020\" src=\"https:\/\/www.urolon.com\/wp-content\/uploads\/2022\/02\/Modellen3-1024x1024.jpg\" class=\"attachment-large size-large\" alt=\"\" srcset=\"https:\/\/www.urolon.com\/wp-content\/uploads\/2022\/02\/Modellen3-1024x1024.jpg 1024w, https:\/\/www.urolon.com\/wp-content\/uploads\/2022\/02\/Modellen3-1000x1000.jpg 1000w, https:\/\/www.urolon.com\/wp-content\/uploads\/2022\/02\/Modellen3-768x768.jpg 768w, https:\/\/www.urolon.com\/wp-content\/uploads\/2022\/02\/Modellen3-1536x1536.jpg 1536w, https:\/\/www.urolon.com\/wp-content\/uploads\/2022\/02\/Modellen3-2048x2048.jpg 2048w\" sizes=\"auto, (max-width: 1020px) 100vw, 1020px\" \/>\t\t\t\t\t\t\n\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\n<style>\n#image_1242097839 {\n  width: 100%;\n}\n<\/style>\n\t<\/div>\n\t\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\n\t\n\n\t<div id=\"col-859166568\" class=\"col medium-4 small-12 large-4\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n\t<div class=\"img has-hover x md-x lg-x y md-y lg-y\" id=\"image_693479338\">\n\t\t\t\t\t\t\t\t<div class=\"img-inner dark\" >\n\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"1020\" height=\"1020\" src=\"https:\/\/www.urolon.com\/wp-content\/uploads\/2022\/02\/Modellen2-1024x1024.jpg\" class=\"attachment-large size-large\" alt=\"\" srcset=\"https:\/\/www.urolon.com\/wp-content\/uploads\/2022\/02\/Modellen2-1024x1024.jpg 1024w, https:\/\/www.urolon.com\/wp-content\/uploads\/2022\/02\/Modellen2-1000x1000.jpg 1000w, https:\/\/www.urolon.com\/wp-content\/uploads\/2022\/02\/Modellen2-768x768.jpg 768w, https:\/\/www.urolon.com\/wp-content\/uploads\/2022\/02\/Modellen2-1536x1536.jpg 1536w, https:\/\/www.urolon.com\/wp-content\/uploads\/2022\/02\/Modellen2-2048x2048.jpg 2048w\" sizes=\"auto, (max-width: 1020px) 100vw, 1020px\" \/>\t\t\t\t\t\t\n\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\n<style>\n#image_693479338 {\n  width: 100%;\n}\n<\/style>\n\t<\/div>\n\t\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\n\t\n<\/div>\n<p class=\"p1\"><b>September 2019<\/b><\/p>\n<p class=\"p1\">AQLANE Medical\u2122 is pleased to announce that our 12-month clinical data abstract has been accepted for ePoster Presentation at the ICS 2019 Meeting 3-6 September in Gothenburg, Sweden.<\/p>\n<p class=\"p1\">Concluding message: The study shows that the PCL-based bioresorbable urethral implant treatment is safe and effective for women with mild to moderate SUI, resulting in improvements in both SUI severity and QoL. As the study is ongoing (up-to 2 years follow-up), data is subject to change.<\/p>\n<p class=\"p1\">Please click here to read the full abstract and here to download the ePoster.<\/p>\n<p>\u00a0<\/p>\n<p class=\"p1\"><b>July 2019<\/b><\/p>\n<p class=\"p1\">In summary, the 18-month analysis shows Urolon\u2122 as a safe and effective treatment option for females with mild to moderate SUI who have attempted or failed pelvic floor muscle training. Results show improvements in both SUI severity and QoL with only 6 subjects that reported treatment-related AE\u2019s which supports a high safety profile. Anecdotal reports from all clinical study sites confirms the performance of Urolon\u2122 as superior in comparison to current urethral bulking agents on the market. The bioresorption profile of Urolon\u2122 is an attractive characteristic and feedback from urologists, gynecologists and urogynecologists alike, suggest this is a highly sought-after feature. As the study is ongoing additional data will be provided at 24-month follow-up to further support the safety and efficacy profile of Urolon\u2122.<\/p>\n\t<div id=\"gap-292488203\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-292488203 {\n  padding-top: 30px;\n}\n<\/style>\n\t<\/div>\n\t\n\n  <div class=\"banner has-hover\" id=\"banner-1132563036\">\n          <div class=\"banner-inner fill\">\n        <div class=\"banner-bg fill\" >\n            <img loading=\"lazy\" decoding=\"async\" width=\"2560\" height=\"765\" src=\"https:\/\/www.urolon.com\/wp-content\/uploads\/2022\/02\/data1.png\" class=\"bg attachment-original size-original\" alt=\"\" \/>                                    \n                    <\/div>\n\t\t\n        <div class=\"banner-layers container\">\n            <div class=\"fill banner-link\"><\/div>            \n        <\/div>\n      <\/div>\n\n              <div class=\"height-fix is-invisible\"><img loading=\"lazy\" decoding=\"async\" width=\"2560\" height=\"765\" src=\"https:\/\/www.urolon.com\/wp-content\/uploads\/2022\/02\/data1.png\" class=\"attachment-original size-original\" alt=\"\" srcset=\"https:\/\/www.urolon.com\/wp-content\/uploads\/2022\/02\/data1.png 2560w, https:\/\/www.urolon.com\/wp-content\/uploads\/2022\/02\/data1-300x90.png 300w, https:\/\/www.urolon.com\/wp-content\/uploads\/2022\/02\/data1-1024x306.png 1024w, https:\/\/www.urolon.com\/wp-content\/uploads\/2022\/02\/data1-768x230.png 768w, https:\/\/www.urolon.com\/wp-content\/uploads\/2022\/02\/data1-1536x459.png 1536w, https:\/\/www.urolon.com\/wp-content\/uploads\/2022\/02\/data1-2048x612.png 2048w\" sizes=\"auto, (max-width: 2560px) 100vw, 2560px\" \/><\/div>\n            \n<style>\n#banner-1132563036 {\n  background-color: rgb(255,255,255);\n}\n<\/style>\n  <\/div>\n\n\n\t<div id=\"gap-2001105955\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-2001105955 {\n  padding-top: 30px;\n}\n<\/style>\n\t<\/div>\n\t\n<p class=\"p1\"><b>April 2019<\/b><\/p>\n<p class=\"p1\">AQLANE Medical\u2122 is pleased to announce that our 12-month clinical data abstract has been accepted for Oral Presentation at the UKCS 2019 Meeting, 24-26 April in Manchester, United Kingdom.<\/p>\n<p class=\"p1\">Please click here to read the full abstract.<\/p>\n<p class=\"p1\"><b>November 2018<\/b><\/p>\n<p class=\"p1\">In summary, the 12-month intermediate analysis shows Urolon\u2122 as a safe and effective treatment option for woman with mild to moderate SUI who have attempted or failed pelvic floor muscle training. Results show improvements in SUI severity and QoL (see figure 1-3) with only few mild treatment-related AE\u2019s which supports a high safety profile. The clinical study sites expressed their high satisfaction with the performance of Urolon\u2122. The bioresorption profile of Urolon\u2122 is an attractive characteristic and feedback from urologists, gynecologists and urogynecologists alike, suggest this is a highly sought-after feature of a urethral implant. As the study is ongoing additional data will be provided at 18- and 24-month follow-up to further confirm the safety and efficacy profile of Urolon\u2122.<\/p>\n<div class=\"row\"  id=\"row-1573298154\">\n\n\t<div id=\"col-970911103\" class=\"col medium-4 small-12 large-4\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n\t<div class=\"img has-hover x md-x lg-x y md-y lg-y\" id=\"image_76039058\">\n\t\t\t\t\t\t\t\t<div class=\"img-inner dark\" >\n\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"500\" height=\"500\" src=\"https:\/\/www.urolon.com\/wp-content\/uploads\/2022\/02\/Figuur1.jpg\" class=\"attachment-large size-large\" alt=\"\" \/>\t\t\t\t\t\t\n\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\n<style>\n#image_76039058 {\n  width: 100%;\n}\n<\/style>\n\t<\/div>\n\t\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\n\t\n\n\t<div id=\"col-336376109\" class=\"col medium-4 small-12 large-4\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n\t<div class=\"img has-hover x md-x lg-x y md-y lg-y\" id=\"image_1334398469\">\n\t\t\t\t\t\t\t\t<div class=\"img-inner dark\" >\n\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"500\" height=\"500\" src=\"https:\/\/www.urolon.com\/wp-content\/uploads\/2022\/02\/Figuur2.jpg\" class=\"attachment-large size-large\" alt=\"\" \/>\t\t\t\t\t\t\n\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\n<style>\n#image_1334398469 {\n  width: 100%;\n}\n<\/style>\n\t<\/div>\n\t\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\n\t\n\n\t<div id=\"col-461288880\" class=\"col medium-4 small-12 large-4\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n\t<div class=\"img has-hover x md-x lg-x y md-y lg-y\" id=\"image_470267566\">\n\t\t\t\t\t\t\t\t<div class=\"img-inner dark\" >\n\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"500\" height=\"500\" src=\"https:\/\/www.urolon.com\/wp-content\/uploads\/2022\/02\/Figuur3.jpg\" class=\"attachment-large size-large\" alt=\"\" \/>\t\t\t\t\t\t\n\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\n<style>\n#image_470267566 {\n  width: 100%;\n}\n<\/style>\n\t<\/div>\n\t\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\n\t\n<\/div>\n<p class=\"p1\"><b>August 2018<\/b><\/p>\n<p class=\"p1\">AQLANE Medical\u2122 is pleased to announce that our 6-month clinical data abstract has been accepted for Poster Presentation at the ICS 2018 Meeting 28-31 August in Philadelphia, USA.<\/p>\n<p class=\"p1\">Concluding message: QoL measures are an essential end-point for measuring patients perceptions of the effects of incontinence treatments. Improvements in QoL shown here further demonstrate the efficacy of this PCL-based bulking agent. In addition to its efficacy, bioresorption is an attractive safety feature of the PCL-based bulking agent when compared to permanent materials. Preliminary results suggest that the bioresorbable PCL-based bulking agent is a promising safe and effective treatment option, and a valuable addition to the current treatment armament for female patients with mild to moderate SUI, who attempted and failed prior pelvic floor muscle training.<\/p>\n<p class=\"p1\">Please click here to read the full abstract and here to download the ePoster.<\/p>\n<p class=\"p1\"><b>October 2017<\/b><\/p>\n<p class=\"p1\">AQLANE Medical\u2122 is pleased to announce that abstract entitled \u201cTreatment with a polycaprolactone-based bioresorbable collagen stimulator (BCS) for mild to moderate SUI\u201d showcasing interim data from our European pivotal trial was accepted for a poster presentation by the EUGA Scientific Committee.<\/p>\n<p class=\"p1\"><b>July 2017<\/b><\/p>\n<p class=\"p1\">AQLANE Medical\u2122 is pleased to announce that patient enrollment is completed and all subjects are treated in their multicenter European clinical trial entitled \u201cThe use of a Polycaprolactone Based Bulking Agent for the Treatment of Female Stress Urinary Incontinence (SUI), a Pivotal Trial\u201d.<\/p>\n<p class=\"p1\"><b>September 2016<\/b><\/p>\n<p class=\"p1\">AQLANE Medical\u2122 is pleased to announce the first patient has been enrolled and treated in their multicenter clinical trial entitled \u201cThe use of a Polycaprolactone Based Bulking Agent for the Treatment of Female Stress Urinary Incontinence (SUI), a Pivotal Trial\u201d.<\/p>\n<p class=\"p1\"><b>July 2016<\/b><\/p>\n<p class=\"p1\">AQLANE Medical\u2122 received approval to start their multicenter clinical trial in the Netherlands. Following the University Hospital in Antwerp (UZA), Belgium, two Dutch sites will start patient enrollment; the Catharina Hospital in Eindhoven and the Laurentius Hospital in Roermond.<\/p>\n<div class=\"row\"  id=\"row-1836407343\">\n\n\t<div id=\"col-1194124294\" class=\"col medium-7 small-12 large-7\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n\n  <div class=\"banner has-hover\" id=\"banner-1962322666\">\n          <div class=\"banner-inner fill\">\n        <div class=\"banner-bg fill\" >\n            <img loading=\"lazy\" decoding=\"async\" width=\"2560\" height=\"400\" src=\"https:\/\/www.urolon.com\/wp-content\/uploads\/2022\/02\/logos.png\" class=\"bg attachment-original size-original\" alt=\"\" \/>                                    \n                    <\/div>\n\t\t\n        <div class=\"banner-layers container\">\n            <div class=\"fill banner-link\"><\/div>            \n        <\/div>\n      <\/div>\n\n              <div class=\"height-fix is-invisible\"><img loading=\"lazy\" decoding=\"async\" width=\"2560\" height=\"400\" src=\"https:\/\/www.urolon.com\/wp-content\/uploads\/2022\/02\/logos.png\" class=\"attachment-original size-original\" alt=\"\" srcset=\"https:\/\/www.urolon.com\/wp-content\/uploads\/2022\/02\/logos.png 2560w, https:\/\/www.urolon.com\/wp-content\/uploads\/2022\/02\/logos-300x47.png 300w, https:\/\/www.urolon.com\/wp-content\/uploads\/2022\/02\/logos-1024x160.png 1024w, https:\/\/www.urolon.com\/wp-content\/uploads\/2022\/02\/logos-768x120.png 768w, https:\/\/www.urolon.com\/wp-content\/uploads\/2022\/02\/logos-1536x240.png 1536w, https:\/\/www.urolon.com\/wp-content\/uploads\/2022\/02\/logos-2048x320.png 2048w\" sizes=\"auto, (max-width: 2560px) 100vw, 2560px\" \/><\/div>\n            \n<style>\n#banner-1962322666 {\n  background-color: rgb(255,255,255);\n}\n<\/style>\n  <\/div>\n\n\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\n\t\n<\/div>\n<p class=\"p1\">The clinical trial is registered in the Dutch Trial Register (NTR) under number 6002, please click here to read the trial info.<\/p>\n<p class=\"p1\"><b>May 2016<\/b><\/p>\n<p class=\"p1\">AQLANE Medical\u2122 received approval to start their multicenter clinical trial in Belgium. The University Hospital in Antwerp (UZA) is the first hospital to enroll patients into this 2-year study.<\/p>\n<p class=\"p1\"><b>September 2015<\/b><\/p>\n<p class=\"p1\">AQLANE Medical\u2122 initiated a prospective, pivotal trial to study the safety and efficacy of Urolon\u2122, our PCL-based bulking agent for female stress urinary incontinence (SUI). Site selection is completed and patient enrollment is underway.<\/p>\n\t<div id=\"gap-130667356\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-130667356 {\n  padding-top: 30px;\n}\n<\/style>\n\t<\/div>\n\t\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-1516427352 > .col-inner {\n  padding: 0px 0px 0px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n<\/div>\n\t\t<\/div>\n\n\t\t\n<style>\n#section_1866695324 {\n  padding-top: 120px;\n  padding-bottom: 120px;\n  background-color: rgb(255,255,255);\n}\n<\/style>\n\t<\/section>\n\t\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":0,"parent":1074,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"page-blank.php","meta":{"_bbp_topic_count":0,"_bbp_reply_count":0,"_bbp_total_topic_count":0,"_bbp_total_reply_count":0,"_bbp_voice_count":0,"_bbp_anonymous_reply_count":0,"_bbp_topic_count_hidden":0,"_bbp_reply_count_hidden":0,"_bbp_forum_subforum_count":0,"inline_featured_image":false,"footnotes":""},"class_list":["post-1642","page","type-page","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Clinical Data - Urolon<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.urolon.com\/nl\/about-urolon\/clinical-data\/\" \/>\n<meta property=\"og:locale\" content=\"nl_NL\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Clinical Data - Urolon\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.urolon.com\/nl\/about-urolon\/clinical-data\/\" \/>\n<meta property=\"og:site_name\" content=\"Urolon\" \/>\n<meta property=\"article:modified_time\" content=\"2026-06-10T19:48:37+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Geschatte leestijd\" \/>\n\t<meta name=\"twitter:data1\" content=\"5 minuten\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.urolon.com\\\/nl\\\/about-urolon\\\/clinical-data\\\/\",\"url\":\"https:\\\/\\\/www.urolon.com\\\/nl\\\/about-urolon\\\/clinical-data\\\/\",\"name\":\"Clinical Data - Urolon\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.urolon.com\\\/#website\"},\"datePublished\":\"2022-02-03T22:39:31+00:00\",\"dateModified\":\"2026-06-10T19:48:37+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.urolon.com\\\/nl\\\/about-urolon\\\/clinical-data\\\/#breadcrumb\"},\"inLanguage\":\"nl-NL\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.urolon.com\\\/nl\\\/about-urolon\\\/clinical-data\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.urolon.com\\\/nl\\\/about-urolon\\\/clinical-data\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.urolon.com\\\/nl\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Urolon\",\"item\":\"https:\\\/\\\/www.urolon.com\\\/nl\\\/about-urolon\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Clinical Data\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.urolon.com\\\/#website\",\"url\":\"https:\\\/\\\/www.urolon.com\\\/\",\"name\":\"Urolon\",\"description\":\"Be all yourself\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.urolon.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"nl-NL\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Clinical Data - Urolon","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.urolon.com\/nl\/about-urolon\/clinical-data\/","og_locale":"nl_NL","og_type":"article","og_title":"Clinical Data - Urolon","og_url":"https:\/\/www.urolon.com\/nl\/about-urolon\/clinical-data\/","og_site_name":"Urolon","article_modified_time":"2026-06-10T19:48:37+00:00","twitter_card":"summary_large_image","twitter_misc":{"Geschatte leestijd":"5 minuten"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.urolon.com\/nl\/about-urolon\/clinical-data\/","url":"https:\/\/www.urolon.com\/nl\/about-urolon\/clinical-data\/","name":"Clinical Data - Urolon","isPartOf":{"@id":"https:\/\/www.urolon.com\/#website"},"datePublished":"2022-02-03T22:39:31+00:00","dateModified":"2026-06-10T19:48:37+00:00","breadcrumb":{"@id":"https:\/\/www.urolon.com\/nl\/about-urolon\/clinical-data\/#breadcrumb"},"inLanguage":"nl-NL","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.urolon.com\/nl\/about-urolon\/clinical-data\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.urolon.com\/nl\/about-urolon\/clinical-data\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.urolon.com\/nl\/"},{"@type":"ListItem","position":2,"name":"Urolon","item":"https:\/\/www.urolon.com\/nl\/about-urolon\/"},{"@type":"ListItem","position":3,"name":"Clinical Data"}]},{"@type":"WebSite","@id":"https:\/\/www.urolon.com\/#website","url":"https:\/\/www.urolon.com\/","name":"Urolon","description":"Be all yourself","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.urolon.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"nl-NL"}]}},"_links":{"self":[{"href":"https:\/\/www.urolon.com\/nl\/wp-json\/wp\/v2\/pages\/1642","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.urolon.com\/nl\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.urolon.com\/nl\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.urolon.com\/nl\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.urolon.com\/nl\/wp-json\/wp\/v2\/comments?post=1642"}],"version-history":[{"count":1,"href":"https:\/\/www.urolon.com\/nl\/wp-json\/wp\/v2\/pages\/1642\/revisions"}],"predecessor-version":[{"id":1660,"href":"https:\/\/www.urolon.com\/nl\/wp-json\/wp\/v2\/pages\/1642\/revisions\/1660"}],"up":[{"embeddable":true,"href":"https:\/\/www.urolon.com\/nl\/wp-json\/wp\/v2\/pages\/1074"}],"wp:attachment":[{"href":"https:\/\/www.urolon.com\/nl\/wp-json\/wp\/v2\/media?parent=1642"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}